There is substantial evidence to suggest that inherited predisposition is an important factor in the incidence of colorectal adenomas and carcinomas (reviews by Bishop & Burt et al., 1991) . The (Bulow, 1987) . HNPCC is a clinically distinct non-polyposis syndrome which is dominantly inherited and predisposes to colorectal cancer at an early age without the numerous polyps seen in FAP (Lynch et al., 1988) . In addition, a poorly defined category of non-FAP germline susceptibility to coloretal cancer probably makes up the bulk of the genetic input into the incidence of the disease (Dunlop, 1992) . HNPCC accounts for around 5% of all cases of colorectal cancer, and 39% of all colorectal cancer patients below the age of 50 (Lynch et al., 1985a; Mecklin, 1987) .
A number of identified genes are known to be involved in the development of colorectal cancer: the APC (adenomatous polyposis coli) and MCC (mutated in colon cancer) genes in chromosome 5q21 Nishisho et al., 1991) , the DCC (deleted in colon cancer) gene on chromosome 18q (Fearon et al., 1990) and the p53 gene on chromosome l7p13 (Baker et al., 1989) . Constitutional mutations in the APC gene have been shown to be the causative genetic abnormality in FAP Nagase et al., 1992; Groden et al., 1993) . There is some evidence for genetic linkage to the Kidd blood group on chromosome 18q with one large family giving a significant lod score using Kidd blood markers (Lynch et al., 1985b) . By inference, the DCC gene which is close to the Kidd blood group locus, might be the gene involved. However linkage to DCC has been excluded in a number of families (Dunlop, M.G., unpublished data; Peltomaki et al., 1991) . Notwithstanding these findings it is possible that a minority of families may be linked to a locus on 18q.
Recent evidence has shown that inheritance of a mutation in the p53 gene is the primary cause for hereditary predisposition to cancer in patients with the Li-Fraumeni syndrome (Malkin et al., 1990; Srivastava et al., 1990) , in which the cancers characteristic of the syndrome are predominantly breast, brain and soft tissue sarcomas, osteosarcoma, leukaemia and adrenocortical carcinoma (Li & Fraumeni, 1969) . Other cancers have been infrequently found, including primary colon cancer (Law et al., 1991; Malkin et al., 1992) . In addition, some cancer families which are not classic Li-Fraumeni families carry constitutional p53 mutations (Prosser et al., 1992) . While colorectal cancer is not common in the Li-Fraumeni syndrome, somatic mutations in the p53 gene occur in a high proportion of colorectal tumours (Baker et al., 1989; Hollstein et al., 1991 We have identified a number of Scottish patients with histologically confirmed non-FAP colon or rectal adenocarcinoma occurring under the age of 40 years. This extreme early age of onset compares with the mean age of onset of 70.25 years in a local consecutive series of 776 patients with colorectal cancer (data not shown). The selection criteria for inclusion in this study were (a) age less than 30 years at diagnosis, with or without a family history of the disease (n = 25), and (b) age less than 40 years at diagnosis with two or more first degree relatives affected by colorectal cancer (n = 10). Group (b) patients therefore fulfil the empirical criteria for classification as HNPCC. Cases due to FAP, or arising in association with ulcerative colitis, were excluded. There were no clinical or pathological features of the tumours arising in the study group which distinguished them from the local consecutive series mentioned above, including pathological (Duke's) stage, site and degree of differentiation. The cases with a family history were all members of site specific colon cancer families (Lynch type I). There was no excess of breast or gynaecological malignancies in the relatives of the probands in which extended pedigrees of 1st and 2nd degree kinships were ascertained and verified from hospital records, pathology reports, cancer registration and central public records for cause of death.
DNAs were extracted from whole blood using standard procedures. Exons 4-9 were amplified in three segments (Table I for oligonucleotides, their location in the p53 gene, and fragment sizes) using polymerase chain reaction (PCR). The PCR products were excised from TAE/low melting agarose gels (BRL) and gene-cleaned (Stratech Scientific) following the instruction of the manufacturer. The exons were screened for point mutations using the technique of chemical cleavage of mismatch, or HOT (for hydroxylamine and osmium tetroxide used in the procedure) as described (Cotton et al., 1988; Prosser et al., 1990 Prosser et al., , 1991 .
No mutant band was observed in any of the exons of the p53 gene in any of the individuals included in the study (see Figure 1 for a representative result), although a number of bands due to known polymorphisms were identified. Lynch et al. (1992) also failed to detect constitutional mutations in exons 5-9 of the p53 gene in 11 HNPCC pedigrees analysed by cloning and sequencing. Exons 4-9 of the p53 gene, which were screened in this study, have been shown to contain more than 95% of previously identified somatic mutations (Hollstein et al., 1991; Caron de Fromental & Soussi, 1992) , and to encompass the sites of all discovered germline mutations, the limits being exon 4 (Toguchida et al., 1992) and exon 9 (Malkin et al., 1992) . In view of these findings, and the high degree of sensitivity of mutation detection by the HOT technique (Condie et al., 1993) , the results of our study together with those of Lynch et al. (1992) , indicate that susceptibility to colorectal cancer is unlikely to be conferred by constitutional p53 mutations. Even if such mutations are present, it would be at an extremely low frequency and they are therefore not the primary cause for hereditary susceptibility to non-polyposis colorectal cancer syndromes.
